The future of Covid, and some updates on the fight against it

A while back, I summarized a theory that the Covid virus is unlikely to pick up the number of mutations it would need if it’s going to evade the vaccines. I felt a lot better after reading that, but let’s look at an opposing theory so we can all get depressed together.

This theory raises the possibility that in addition to the virus picking up small mutations over time (that’s called antigenic drift), there’s the possibility of antigenic shift, which involves more dramatic changes caused by the virus recombining with other human coronaviruses. Viruses do that. Basically, they hold a swap meet. Or a bring and buy sale if you’re more used to them. They don’t actually use money–their evolution hasn’t brought them to that exalted stage–but they do trade strategies for making money-using creatures sick.

If they swap the right bits of knowledge, the current crop of vaccines will need to be re-engineered. We’ll all move back to Go and start the game over again.

It’s also possible that Covid will infect animals we share space with and then cross back to humans in some more powerful form. That’s reverse zoonosis.

Irrelevant photo: Japanese anemone, with a bite out of it. That’s to prove the beauty of imperfection and all that deep philosophical stuff.

As a general rule, long-term evolution favors viruses that don’t make their hosts too sick. The very sick tend to crawl away somewhere and keep their germs to themselves, which (seeing this from the germs’ point of view) isn’t an efficient use of a host. And the dead die, which also limits their opportunities to share. That’s even more inefficient. 

From that base, any number of people argue that (after a trail of death and destruction) epidemic diseases get milder over time. Everyone who doesn’t die lives happily ever after. They point to the 1918 flu epidemic (or the Black Death, or some other cheery moment in human history) and assure us that this is the natural order of things. 

According to this theory, that is indeed one possibility but it’s not the only one. 

The British government’s group of scientific advisors, SAGE, thinks the virus isn’t likely to become less virulent in the short term. (Virulence isn’t about a disease’s ability to spread–that’s transmissibility. It’s about how sick it makes a person.) SAGE considers that a long-term possibility, but it also considers it a realistic possibility that a more virulent strain will emerge. 

Sorry. I don’t create the possibilities, I just write about them.

So what direction will it evolve in? Basically, no one’s sure.  

However, all isn’t lost. A lot of work’s being done on how to cope with Covid.

 

The Covid-killing mask 

A group of researchers have created a surgical mask that deactivates not just the Covid virus but any enveloped virus (that includes the flu), plus some antibiotic-resistant bacteria like a couple of the staphylococci. 

What’s an enveloped virus? I’m so glad you asked, because I have an answer right here in my pocket. It’s “any virus in which a nucleoprotein core is surrounded by a lipoprotein envelope consisting of a closed bilayer of lipid derived from that of the host cell’s membrane(s), with glycoprotein.”

You’re welcome. I didn’t understand it either, but I’m glad to get it out of my pocket.

The masks are the first ones that don’t just protect both the rest of the world from the wearer but also protect the wearer from the rest of the world. 

Okay, not completely, but virus- and staphylococcuses-wise, it will. If someone’s trying to hit you on the head with a hammer, the masks are no help at all.

I’ve seen masks promoted as antiviral. Advertising copy for masks with a copper layer, for example, talks about copper’s antiviral properties without actually claiming that the masks will kill Covid. From what I’ve read, they don’t have enough copper to do more than provide carefully worded hype.

The new masks are called FFP Covid masks, they come in adult and child sizes, and according to the article I read they’re very affordable.

How affordable is very affordable? After bumping around the internet for a while, I found some on sale for one euro. That’s not bad, but whether it’s affordable depends on how much you have in your wallet, and how long it takes to renew itself once you pull some of it out to buy masks.

Not to mention how many other calls you have on it.

Are the masks reusable? That’ll affect people’s opinion of their affordability, and the definitive answer is, I’m not sure. They look disposable, but that’s strictly a guess. 

Another limiting factor for most of us–since this is an English-language site–is that the only place I could find them for sale is in Spain, which is where they were developed. Presumably they’ll make their way into the rest of the world at some point. 

Still, whatever the mask’s immediate impact, it’s an important step.

 

Quick updates

Multiple new Covid treatments and vaccines are in the works. Here’s a sampling:

An inhalable powder works against Covid, MERS, and one version of the flu. In animals. It has yet to be tried in  humans–at least in this form. As a pill, it’s used against leukemia, but when you turn it into a powder and inhale it, it becomes a whole ‘nother thing. In addition to landing in a different part of the body and possibly needing a different dose, it opens up the possibility of Covid treatment taking on some bad-boy chic: You roll up a hundred-dollar bill and snort your meds.  

*

Repurposing a drug that’s already in use to treat a new disease isn’t, it turns out, as simple as it sounds. You may have to shift from a pill to a powder. You may need a dose so high that it turns toxic, at which point you may need to rethink the whole idea.

*

Another drug that’s already in use, this one to treat fatty substances in the blood (no, don’t ask me), could reduce Covid infection by 70%. Could. So far, it’s worked only in human cells in the lab. Two clinical trials are underway, though.

*

An antiviral called molnupiravir halves the chances of an infected, high-risk person needing hospitalization or dying from Covid, and Merck will be asking for emergency approval in the U.S. Molnupiravir doesn’t seem to be as effective as monoclonal antibodies, but because it’s a pill it can be used outside of hospital settings, so it’s much easier to use.. 

Down sides? It costs $700 for a five-day course of treatment, which makes it cheaper than and easier to type than monoclonal antibodies, but it’s still expensive. And some experts are warning about potential side effects. Plus it doesn’t seem to help patients who are already sick enough to be hospitalized. So although it’s gotten a lot of press coverage and is, without question, important, it’s not the answer to all problems.

Other antiviral pills are also in the works. 

*

Vaccines? Why yes. A new vaccine in development uses only a single shot and can be stored at room temperature for up to a month. In trials with primates, it gave near-complete immunity that stayed at its peak level for eleven months.

It’s called an AAVCOVID vaccine, AAV being the vector the vaccine uses. 

What am I talking about? The vector’s the horse the vaccine rides in on. Or if you want to sound marginally more sensible, it’s the  strategy the developers use. I’m not going to try to explain this one, because I’m pretty sure I’ll get it wrong. Let’s just say that if this strategy works, it’ll help get the vaccine out to places where refrigeration’s a barrier. 

The team that’s developing it is also exploring needle-less delivery systems.

*

Another vaccine in the works is using a new model that I’d love to explain but I’m not even close to understanding it, so let me quote: It combines “the advantages of the two types of traditional vaccines—virus-based vaccines and protein-based vaccines—by preparing a bacterial protein that self-assembles into a virus-like particle. By displaying a COVID-19 protein on the surface of this virus-like particle, researchers produced a novel vaccine that is well recognized by the mammalian immune system, but yet does not have any viral infectivity.”

If I understand that correctly, it behaves like one of those transformers kids used to play with, and for all I know still do. You introduce it into a body as a motorcycle, it clicks a few of its own pieces, turns green, and suddenly it’s the Hulk, chasing down unsuspecting Covid viruses.

Early tests show it being effective against the Covid variants and setting up a strong immune response.

Come to me anytime you need a high-grade scientific explanation.

 

Long Covid numbers

I’ve found some numbers on long Covid, finally: About a third of the people who come down with Covid get at least one long Covid  symptom. 

First question, who are we talking about when we say people who get Covid? As far as I can tell, it’s people who actually got sick, because the article talks about them recovering. So I think we can rule out anyone who gets infected but stays asymptomatic. 

We need all the good news we can get, so let’s play nice and say thanks for that.

Second question, how are they defining long Covid? You get to pick from nine core symptoms, and they have (or it has, if you only get one) to last at least 90 days. The most common ones are breathing problems, abdominal symptoms, fatigue, pain, and anxiety and depression.They’re more common in people who’ve been hospitalized and slightly more common in women than in men. The same symptoms occur after the flu, but they’re 1.5 times more common after Covid.

Next shred of good news? If long Covid symptoms are more common in people who’ve been hospitalized, less than a third of people with milder symptoms are likely to come down with it. 

What will it mean if Covid stops being a pandemic?

The talk these days is that Covid will eventually lose its pandemic status and turn into an ordinary, house-trained endemic disease–the kind of disease that circulates in a population and gets us sick but doesn’t give us nightmares, overwhelm hospitals, or kill huge numbers of people. And (they say) this will happen because of two factors: vaccination and the natural immunity that people who’ve been exposed and survived gain. 

What are the odds, though, that Covid will pull a fast one and evade our immunities

Not that high, according to a study that tried to replicate Covid’s mutation pattern using a harmless virus. To completely outrun the immunity we gain from either exposure or vaccination, the virus would have to draw twenty of the right cards out of the mutation deck. 

How many cards are we playing with? I’m not sure. As far as I can figure out, the rules of the game keep shifting. But the scientists–the people who study this stuff, as opposed to the people who read one lone article and call themselves experts–say it would be one hell of a trick for it to pick all twenty.

Irrelevant photo: The north Cornish coast.

On top of that, the virus isn’t the only thing that evolves. So does the human immune system. After it’s met the virus, either in the form of an infection or a vaccine, it sits down and plays with its antibodies. Think of it as a kid with a Lego set. It spends months working out shapes that bind ever more tightly to Covid’s spike proteins. 

People who’ve gotten an mRNA vaccine and also have naturally occurring immunity to Covid have the strongest defense. It’s possible that booster shots will create the same flexible immunity, although that hasn’t been demonstrated yet.

So as surely as the virus doesn’t keep one single form, neither does the human immune system. We will, eventually, get through this mess, although the question is at what cost. 

 

How can we measure Covid’s impact?

In the US, Covid has now killed as many people as the 1918-19 flu epidemic. I’d love to give you comparisons for other countries, but that’s all I’ve found.

To put that into perspective, in 1918 the population of the US was a third of what it is now, so it killed a larger percentage of people. On the other hand, if we’re comparing the inherent danger of the two diseases, massive advances in medicine have kept the death toll lower than it would otherwise have been. 

There must be a dozen ways to measure Covid’s impact, but one of them is cold, hard cash. Again in the US, it’s cost almost $6 billion to hospitalize the unvaccianted in just three months, from June through August 2021

The study’s authors say that’s probably an underestimate.

Yet another study says that by March of 2021, Covid had taken 9 million years of life from the U.S. population. Instead of measuring excess deaths, it looked at the mortality burden of the pandemic. 

What the hell does that mean? You would have to ask, wouldn’t you? The study looked at QALYs, or quality adjusted life years, using them to measure the length of time people would have lived if they hadn’t, um, died. It says that people between 25 and 64 lost 4.67 million years of life, and Black and Hispanic communities were hit hardest, especially men in those groups who were 65 and older.

I know, I know, I’m supposed to be writing about Britain. What can I tell you? Bloggers are irresponsible cheats.

 

Question: If you’re not vaccinated against Covid, will gargling with iodine help? 

Answer: In a test tube, povidone-iodine kills the Covid virus. 

Further information about that answer: Humans aren’t test tubes. 

What happens in a human, then? There haven’t been many studies, but what few there are hint that iodine can inactivate Covid in the mouth for a time, but not for a long one. What happens after that? The same thing that was happening before. If you breathe in the virus, there’ll be nothing there to stop it. If you’re incubating the virus, it’ll move back into your throat and ditto–there’ll be nothing there to stop it. It’s like wiping your kitchen counters with antiseptic wipes. You kill 99 point something percent of the germs that are present in that moment. Then you and your antiseptic wipes go away and wherever the germs came from, they come back. 

In other words, unless you’re going to spend your days and nights gargling with whatsidone-iodine, this isn’t going to work. 

And have I mentioned that the stuff tastes disgusting and smells just as bad?

Other than that, is there any reason not to use it? Well, it can cause skin irritation–sometimes severe, although not necessarily. It can (rarely) cause your thyroid gland to become inactive, especially if you’re pregnant. And especially if you’re both pregnant and a woman.

The most likely side effect, though, is that it will make you think you’re done something to protect either yourself or the people around you when you haven’t. 

*

On Fridays I usually post something about English or British history or culture. This week I’m doing well to do post anything at all. I hope to be back to full speed eventually. In the meantime, bear with me.

How Covid mutates and why that might be a good thing

There’s good and bad news about the way Covid mutates, and it’s all wrapped around the same bit of information. 

Like most non-experts, I use the word mutate loosely. If something genomeish leads to change, I think it’s a mutation. Which goes to show you what I know.

Covid, it turns out, doesn’t just mutate, it also recombines, meaning it mixes large chunks of its genome, not just single genes. If a mutation’s a typo, recombination is a cut-and-paste error, dumping a largish chunk of text in the wrong place. And while the virus proofreads typos fairly well, it doesn’t catch cut-and-paste problems as effectively.

I’ve had that problem myself. I still wince at something quite horrible that I let go into print because the spelling was right and my eye didn’t pick up the change in meaning. And I’m larger and (I like to think) more complicated than a virus.

Most of those recombination errors, like most mutations, make a mess and that particular virus doesn’t get to leave little virette progeny behind. But some of them work and the virus changes.

Irrelevant photo: One of Janey’s crocuses.

Is recombination what’s happening with Covid? Possibly. The Kent variant has more than a dozen mutations and they seemed to appear all at once. Emphasis on seemed. A lot of what goes on happens in the kitchen while we’re out front cleaning the dining room. Feng Gao, a virologist from China, says we don’t yet have proof of recombination. “Diversity, no matter how much, does not mean recombination. It can well be caused by huge diversification during viral evolution.”

So let’s not get carried away with this. We’re dancing at the edges of what’s known. But (damn, that tune’s catchy, so I’ll do a few more steps) recombination may be how viruses that infect one species jump to another species: by swapping a bit of genetic code .

It’s possible that recombination means a more dangerous virus will appear–either a new one or a more dangerous form of Covid. So there’s our bad news. 

But the good news is that experiments with a mouse coronavirus show that blocking a single enzyme keeps the virus from correcting its typing errors and recombination events happen much less often. If this holds for Covid, the right drug might be able to block recombination and (or maybe that should be or) push the virus to mutate so badly that it ends up in something called error catastrophe–basically, the evolutionary equivalent of falling off a cliff. While dancing to that catchy little tune.

As a way to treat Covid, blocking the enzyme could make antiviral drugs more effective.

The enzyme goes by the name of nsp14-ExoN, which isn’t particularly catchy. If we’re going to be spending time with it, it needs a nickname. But whatever we call it, it’s common in coronaviruses, so if this works it opens up the possibility of curing other coronavirus diseases as well. 

 

Covid variants

If Britain didn’t end up with the world-beating test and trace system Boris Johnson promised us–and believe me, it didn’t–it may have come up with a world-beating strain of Covid instead: the Kent variant; the variant I mentioned that has all those mutations. Sharon Peacock, the director of the Covid-19 Genomics UK consortium tells us it looks likely to sweep the world.

And unlike the test and trace system, we didn’t pay a penny for it.

Go Britain!

The consortium is testing the genomes on a randomly selected 5% to 10% of all positive Covid samples in the country but aims to test them all in order to keep track of how the virus is mutating.

And speaking of variants, the World Health Organization says the small trial that found the AstraZeneca vaccine to be largely ineffective against the South African variant was inconclusive. They’re not saying the vaccine’s definitely effective against it, only that it isn’t definitely ineffective. 

Which is better than nothing. 

 

Covid and Coca Cola

How much space would all the Covid viruses in the world take up if they could be packed neatly for shipping? They’d fill a Coke can

They’d also fill a can of supermarket brand fizzy orange-flavored sugar water, but Covid’s a brand-name kind of virus. Coke it is. So in the scene where someone yells, “Don’t open the can!” for pete’s sake, don’t open the can. You know what happened when Pandora didn’t listen to the warnings?

I’m not telling. But I did give you a link.

 

Spreading the virus

More than half of all Covid cases are spread by people who have no symptoms. They may be less infectious than people who are sick, but they could well make up 80% of the total number of people carrying the disease. And they’re wandering through the world shedding viruses, not lying in bed at home.

*

A study by the U.S. Centers for Disease Control found that wearing two masks can reduce the chance of getting Covid by 90% or more. Yes, not just transmitting but catching the damned thing. 

The study had its limits. It tested a tight-fitting cloth mask over a surgical mask, not two surgical masks and not two cloth ones, and it only looked at one type of cloth masks, although the world’s awash with different types just now. And as the article where I first read this put it, it also didn’t consider “men with beards or children.”

Does having children interfere with the fit of men’s masks more than women’s? Hard to say. The study didn’t test that. 

To keep everything in perspective, an engineering professor says that the only reason to wear two masks is to get a better fit. But the masks most of us wear do fit loosely, so double masking might be worthwhile, no matter who’s right.  

*

Two weeks after U.S. states introduced mask mandates (they haven’t all), the weekly growth in hospitalization rates dropped by 2.9% among people who are 40 to 64. After three weeks it dropped 5.5% among people 18 to 64.

*

Every so often, you’ll find someone saying that Covid’s no more dangerous than a bad outbreak of the flu. So do we have any figures on how much more dangerous it is? 

Yup, some. The risk of death is 3.5 times higher. That number comes from comparing people who are hospitalized with the Covid against those hospitalized with flu. It ignores whatever long- term effects Covid has on the unhospitalized, so I’d say it’s undercounting. Still, it’s a number, and numbers help. 

At least they help most people. 

Covid patients also had one and a half times greater use of the intensive care unit and one and a half times longer hospital stays. And they were more likely to need a ventilator.

In case you think Covid’s only a problem for the old and the ill, not many of the hospitalized Covid patients had other illnesses and 21% were younger than 50. People under 50 made up 24% of the intensive care admissions.

As far as I can see, that doesn’t address the problem of how easily Covid spreads compared to flu. It only compares hospitalized patients.

*

Worldwide, the number of reported Covid cases is down for the fourth week in a row. Take a deep breath. The drop is uneven, it doesn’t count unreported cases, and we forgot to get a guarantee that it won’t go back up, but we have to take our good news where we can get it. This is good news.

 

Is there any news on curing the thing?

In a small study, a common asthma treatment, budesonide, cut the need for hospitalization and urgent care by 90%, and people who took it within seven days of showing symptoms recovered more quickly than the control group. Better yet, it cut the number of people with symptoms that lingered after twenty-eight days. 

As usual, it was a small study–146 people–so it’s preliminary, but budesonide is a well-known and well-studied drug, which would speed the process if it’s adopted.

*

The U.S. Food and Drug Administration has approved a combination of two monoclonal antibodies that can keep high-risk patients from developing Covid that’s severe enough to hospitalize them. A similar drug had already been approved. Both take Covid antibodies and synthesize them so they can be given to patients as a drip. 

And it’s that drip business that’s causing trouble. Initially, getting them from vial (or whatever they come in) into human took an hour. It can now be done in sixteen minutes. But some hospitals have been so overwhelmed they haven’t had time to deal with it. 

*

A team of researchers in China has identified six drugs that the FDA has already approved for other uses that could be repurposed to treat Covid. They whittled that down from 3,769. They still need to be tested in the real world, but already having FDA approval for other purposes means that if they work they could be put to use quickly.

After that, the article went over my head, but it has to do with proteases and substrates, not to mention clades. Have fun.

 

Your feelgood story

New York software developer Huge Ma tried to make his mother a Covid vaccination appointment and discovered that not only did the city and state have different systems that weren’t talking to each other but that there were dozens of separate websites, each one demanding that you sign up a different way.

So he took a couple of weeks and made a free website, TurboVax, that compiles information from the three main city and state sites and sends information on available appointments to Twitter.

It cost him $50 to make.

The difficulty of booking an appointment is one reason–although far from the only one–that vaccines are going disproportionately to white New Yorkers. 

“It’s sort of become a challenge to myself, to prove what one person with time and a little motivation can do,” he said. “This wasn’t a priority for governments, which was unfortunate. But everyone has a role to play in the pandemic, and I’m just doing the very little that I can to make it a little bit easier.”

Fighting to outrun Covid’s mutations

A small test of the Oxford AstraZeneca vaccine has come back with bad news: It gives people only minimal protection against the mild form of the South African Covid variant. It may, though, prevent the most serious forms of the disease.

May. The study involved only 3,000 people–yeah, that’s a small test–and they were young, with an average age of 31. In other words, they’re less likely than older people to get serious Covid, which limits the information the test could deliver. 

AZ is frantically working to tweak its vaccine and expects to have a modified vresion–a booster shot–in the fall. 

But there’s a way to broaden and deepen people’s immunity, according to an expert I can’t link to because he was on the evening news, and that’s to mix vaccines: one dose of AstraZeneca, one of Johnson & Johnson, or of Pfizer. If you were drinking that way, you’d have a hell of a hangover the next morning, but you’re not, you’re sampling vaccines. It’s a way to keep ahead of the virus’s evolution, at least for a while.

The expert said he was fairly sure that the virus will turn out to be seasonal, in which case we should get some breathing room come summer. 

Irrelevant photo: A viola, stolen from last summer. Sorry–it’s late and a couple of other new photos have gone strange on me.

For the UK, the good, if tentative, news is that the South African variant doesn’t seem to have spread widely in the country. Note the weasel-word there: seem. A lot of frantic testing’s going on, trying to identify the variant and contain it. I haven’t seen much about how competently the testing’s being handled. In spite of itself, the government’s managed the vaccination process well. It handed it to the National Health Service instead of contracting it out to Conservative Party donors and friends. Who’d have thought that asking experts to do the job would work so well?

The government’s also done good work in sequencing the virus, which is turning out to be important. But its test and trace system has been an expensive farce. Until further notice, I’m skeptical about them containing the virus. 

A number of people sound like they’re betting on the Kent variant out-competing it, because it’s believed to be more contagious. That’s sort of like–

Well, I was once on a committee with two difficult people who disliked each other. I counted on their dislike to keep them busy enough that the rest of us could get some work done. It wasn’t one of my better ideas. But they were humans, not viruses, although at the time I might have said differently. I don’t see how one variant will block the other, although it might outspread it. 

*

If the AZ virus protects against the serious forms of the virus, what does that leave? Mild or moderate Covid, and they’re nothing you’d volunteer for. 

With mild Covid you get to choose from a list of symptoms: fever, tiredness, muscle aches, headache, sore throat, runny nose, and loss of your sense of smell or taste, but you won’t be breathless and you’ll still be able to take care of yourself. You get to keep your appetite but you may be sad and weepy. So basically, you feel like shit and it lasts seven to ten days. 

And moderate? That’s even more fun. You get to choose from a cough that may be worse than the one they forgot to mention in the mild case, a higher temperature, breathlessness when you do normal stuff like going up stairs but not if you just bump around the kitchen, disturbed sleep, diarrhea, headache, and a dry mouth.But you can still take care of yourself, even if you don’t really want to. You can sit still and not be breathless. You can make sense when you talk to people. You may feel not just weepy or low but downright miserable. You may want to stay in bed for a couple of days. And that goes on for a week or two. 

Is either version likely to lead to long Covid? If anyone knows, they haven’t told me. I’m sure it was just an oversight. 

 

Nanobodies

Could we have some good news, please? Why, yes, I think we can: A bunch of sciency types have found a nanobody that looks like it’ll block Covid.

Let’s chop that into little pieces and try to figure out what I’m talking about. Nanobodies aren’t people who’ve lost a lot of weight. They’re synthetic versions of tiny antibodies that were originally found in llamas and camels–who for the sake of simplicity should probably be known as llamels but aren’t. 

Viruses work by hijacking human cells. Or any cells, but it’s humans we’re interested in just now. To do that, Covid uses those spikes we keep seeing pictures of. I don’t  know about you, but I’m really tired of seeing them. 

The researchers’ idea was to give the virus the right nanobody to grab onto–something that isn’t a human cell. Better yet, the nanobody they found is cheap to produce, easy to store and transport, and can be delivered as an aerosol–a couple of sniffs and you have nanobodies.

The problem–there’s always a problem, isn’t there?–is that the next stage, testing, is expensive and they’re still looking for a partner with money. But pharmaceutical companies are focused on vaccines right now, so they’re not being overwhelmed with offers. Still, it’s hard to believe that someone won’t show up, cash card in hand.

Covid variants, vaccines, and all our clean hands

An assistant professor of food science says that all the hand washing, surface cleaning, and food washing we’re doing may or may not keep Covid in check but has kept us from spreading salmonella, e.coli, and listeria.

It’s not what we’re trying to do, but it is good for us.

There’s no evidence that Covid is spread through food, although that’s not the same as saying that it isn’t spread that way. 

But having (with her team) overdosed on US and Canadian internet videos telling us how to clean everything in sight, Yaohua “Betty” Feng reports that a bunch of them have it wrong. Of the videos telling people how to wash their hands, only 41% of the presenters used soap. The remainder, presumably, relied on good wishes and intense looks. Less than 33% mentioned hand sanitizer. And how many of us, since the start of the pandemic, can get through a day without mentioning hand sanitizer?

Like–I’m going to assume–you, I thought I knew how to wash my hands. I’ve been doing it for better than 70 years now, most of the time without supervision, but there’s no predicting what people will feel the need to learn in these difficult times. Maybe I’ve been doing it wrong. Maybe, for instance, I’ve mistaken my hands for some other body parts.

Irrelevant photo: The first spring violets.

Other videos were about washing produce, and 16% of the presenters used soap while 12% used other chemical cleansers. That sounds promising, but they’re both no-nos. If you don’t rinse them off completely, they can cause diarrhea.

Feng didn’t say this, but you might draw the conclusion that random internet videos aren’t the best places to look for reliable information. Or you might not. 

 

British and (eek!) foreign Covid variants

The British Covid variant, which to make things more complicated is now called the Kent variant, after the part of England where it was first found–

Let’s start that over: The Kent Covid variant has mutated since it was first identified. That’s standard operating procedure in the viral world. Every new infection is a chance for the disease to pick up a mutation. Some of those won’t work well for it and will die out and others will make the disease better at hiding from the immune system. Those are the ones that will spread.

So the Kent variant has picked up a new mutation, and it’s similar to one of the mutations on the South African variant. The going theory is that it evolved the change on its own rather than picking it up like an STD after a one-night stand with the South African variant. Which basically means that two strains of the virus have found the same way to partially evade the human immune system. 

There’s been a lot of focus on stopping, or at least getting control of, the imported Covid variants. In parts of the UK, house-to-house testing is looking for the South African variant.

But that may be a sideshow. Virologist Julian Tang wrote, “Unfortunately, the lack of control of these different variants in the UK may lead this population to become a melting pot for different emerging SARS-COV-2/COVID-19 variants–so we really need to reduce our contact rates to reduce the opportunities for viral spread/replication to reduce the speed with which these different virus variants can evolve.

“Closing borders/restricting travel may help a little with this, but there is now probably already a sufficient critical mass of virus-infected people within the endemic UK population to allow this natural selection/evolution to proceed . . . so we really need to stick to the COVID-19 lockdown restrictions as much as possible.”

In other words, the more the people get infected, the more times the virus gets to mutate, and the more times it mutates the more chances it has of presenting us with a more difficult problem.

There’s something tempting about focusing on imported strains of the virus–Eek! South African! Argh, Brazilian!–but all Covid infections are dangerous. That’s what we need to focus on. 

 

Symptoms

In England–possibly in all of Britain, but don’t trust me on that; I’m at least as confused as you are–the only way to book a Covid test is to claim at least one of three symptoms: cough, loss of smell or taste, and a high temperature. But a GP and senior lecturer in primary care, Alex Sohal, writes that the list should include a runny or blocked nose, a sore throat, hoarseness, muscle pain, fatigue, headache, vomiting, and diarrhea. She’s seen patients come in with them and go on to test positive for Covid.

“These patients have frequently not even considered that they may have Covid-19 and have not self-isolated in the crucial early days when they were most infectious.”

She advocates telling “the public, especially those who have to go out to work and their employers, that even those with mild symptoms . . . should not go out, prioritizing the first five days of self-isolation when they are most likely to be infectious.

“This will help to get—and keep—us out of this indefinite lockdown, as Covid-19 becomes increasingly endemic globally. Ignoring this will be at our peril.”

As it stands, if you have good reason to book a Covid test and don’t have the magic three symptoms, the best thing to do is lie. And almost none of us recognize the full list she gives as possible Covid symptoms.

 

The bad news

Some of the recent Covid mutations have outpaced the monoclonal antibodies we’d all been counting on as a treatment in case we did catch it. 

Mono-whats? 

Okay, if you have to ask, that says we haven’t all been counting on them, but let’s pretend we were so I can explain what’s happening.

Basically, monoclonal antibodies are human antibodies that have been cloned. In this case, they’re antibodies to Covid, and they’ve been used to treat serious Covid cases. The problem is that the humans who developed them did so in the presence of one form of Covid, not all of them. As the virus mutates, they can get left behind.  

They also have another problem, which is that they’re expensive and not easy to make. Other than that, though, they’re great.

 

The good news

At the beginning of February, after a 25-day lockdown, the Isle of Man (population 84,000) lifted almost all  its Covid restrictions. The exceptions are its border controls, which–well, I was going to say they take no prisoners, but in fact taking prisoners is exactly what they do. Someone who tried to get onto the island on a jet ski was jailed for four weeks. 

They seem to have eliminated the virus. Before the lockdown, the island had 400 cases and it’s had 25 deaths. 

The Isle of Man is in the water somewhere between Scotland and Northern Ireland. It’s a self-governing British crown dependency, and don’t ask what that means because it’s complicated and we’re running out of space here in the infinite internet.  

*

Two bits of news about the AstraZeneca vaccine. 

One, a single dose (which is what the UK is focused on at the moment, with the second one delayed for up to twelve weeks) is still 76% effective after three months. That’s not as good as the 82% protection it offers after the second dose, but it ain’t bad, and there’s finally some data backing up the government’s decision to focus on getting an initial dose to as many people as possible–at least for this vaccine.

Delaying the second dose may strengthen the protection, but that’s not definite.

Two, the vaccine may reduce the number of Covid transmissions by two-thirds. That’s not definite–it’s still preliminary–but it’s promising. 

*

A late-stage trial reports that Russia’s Sputnik V vaccine is both safe and 92% effective. It can be stored in a normal refrigerator and comes in two doses, but the second dose is slightly different than the first one. They use different vectors–the neutralized viruses that they ride on. The idea is that this will give the immune system an extra boost and protect people for longer.

 

The little-bit-of-both news

Britain’s vaccinated over 10 million people with at least one dose of one vaccine or another, and the number of hospitalized Covid patients is coming down, but it’s still higher than it was during the first peak of the pandemic. England’s chief medical officer, Chris Whitty, said infection rates are also coming down“but they are still incredibly high.” That may mean, in the American tradition of Groundhog Day, that we get six more weeks of winter. Or lockdown. 

The pandemic news from Britain: A few success stories and some screwups

Europe doesn’t have many Covid success stories, but Finland’s isn’t bad. Its infection rate is the lowest in the European Union (that’s based on a spot check of two weeks that started at the end of October and sloshed over into early November, leaving only a few hard-to-remove stains). It’s infection rate is also five times below the EU average. It was the only EU country whose rate went down in that period.

It responded to the pandemic with an early lockdown, an app, and testing and tracing–things many countries have done but I’m going out on a limb and assuming that they did all of the above competently. It’s odd, but that does make a difference. 

That’s not a comment on how countries like, say, Germany and Wherever Else handled it, because I haven’t been following them. It’s a comment on Britain.

Finland is the only country I know of where 23% of people in a survey said the lockdown had actually improved their lives. Maybe it’s the only country where anybody thought that was a reasonable question.

Nelli Hankonen, an associate professor of social psychology at Helsinki University, said, “In Finnish culture we are not that highly sociable.” So maybe the lockdown took some pressure off people. They could stop trying.

The economy also took less of a hit than most EU economies, with a 6.4% drop compared with 14%. To quote the good prof again, “The economy is structured so that it’s not necessary for a large proportion of the Finnish workforce to be in the workplace.”

*

Screamingly irrelevant photo: Strawberry leaves after a frost. We haven’t had a serious frost yet. This is from last year.

Japan also contained the virus effectively, and a study looked at phone data to see how much people in Tokyo moved around. “We found that 1 week into the state of emergency, human mobility reduced by 50%, which led to a 70% drop in social contacts.”

The government declared a state of emergency in April and asked businesses to close and people to work from home. It also restricted travel, but Japanese law doesn’t allow for a mandatory lockdown.

One of the study’s co-authors said, “With a noncompulsory and nonpharmaceutical intervention, Tokyo had to rely on citizens’ cooperation. Our study shows they cooperated by limiting their movement and contact, subsequently limiting infections,” 

*

What’s happening with the mass testing that England’s banking on? In a real-world trial in early October, the quick-turnaround test at the heart of the strategy, the Opti-Gene test, missed more than 50% of positive cases. That was, I think, compared to the test that’s been in use for some time now.

Local leaders in cities where the test’s scheduled to be used asked for clinical validity data and didn’t get it, but the Department of Health and Social Care said the test was validated in three other trials. 

Somehow, though, it didn’t make the data public.

The tests have cost £323 million.

*

Denmark has discovered that Covid jumped to farmed mink (the country raises a lot of mink for fur; who knew mink was still a thing?), and from them back to some 200 humans. 

That may or may not pose a danger. Viruses do mutate, but so far Covid’s mutations haven’t been significant. The fear is that in jumping to a different species, it may have been forced to pick up more significant mutations, which could, in turn, affect how well vaccines work. Or make it more–

Nah, let’s not even think about that.

So far, there’s no evidence that any of that has happened, and vaccines are fairly easy to tweak–once, of course, we have one or more. The flu vaccine’s tweaked every year in response to educated guesses about the strain of flu that will be circulating. 

People in one affected area of Denmark, northern Jutland, are being urged to stay home to control the spread of the virus variant. And if you think that’s tough, it’s been harder on the mink: 17 million of them are being killed.

*

A few comments I’ve gotten convince me that I should say this: I pour a lot of words onto the virtual page about the many things wrong in Britain’s handling of the virus, and even so I barely touch the surface. But for everything that’s been screwed up, at least Britain hasn’t thrown up its hands and let the virus run wild and there’ve been some efforts to support people who’ve lost their incomes. It’s not enough, it’s not being handled well, people are facing eviction, and food banks are swamped while massive amounts of money are poured into outsourcing companies that make a hash of whatever job they’re given, but in contrast to the way the U.S. has handled the pandemic–

Okay, that’s not a demanding point of comparison, but Britain is at least acknowledging the danger and doing something. I do want to acknowledge that.

*

A year or two  back, an artist created a spoof of some painfully cheery, squeakily white, fifties-era (I think) British kids’ books, the Ladybird series, and she’s just published one about lockdown. By way of a review, I’ll quote one page: 

“We are shopping for emergency supplies.

“‘There is no Lemongrass!’ says Mummy.

“‘Oh dear!’ says John.

“‘I’m starting to understand what life was like in World War II,’ says Mummy.”

*

After the business secretary, Alok Sharma, was exposed to Covid he soldiered on and held meetings with foreign dignitaries anyway, creating a (very minor) scandal. Now it turns out that when he got home he met with (gasp, wheeze) Prince Charles. 

As far as I can tell from the papers, everyone involved seems to have dodged the bullet, but exposing Prince Charles did create a bigger scandal in the press than exposing foreign dignitaries. Because the thing about foreign dignitaries is that they’re foreign. And none of them were (slight pause while I try to assemble some small pretense of respect) royal. 

The funny thing about viruses, though, is that they don’t give a rip who people’s ancestors were. If it’s true, as the proverb says, that a cat may look at a king, it’s also true that a virus will be as happy infecting a prince’s cells as yours or mine.

*

A woman with the main Covid systems was trying to get Covid tests sent for herself and her partner but was told they’d have to go to a test site because their identities couldn’t be verified. They have no car and were responsible enough not to take public transportation when they might be infectious, so they ended up going to a walk-in site 90 minutes away.

The reason she couldn’t get the tests sent, it turns out, is that she didn’t have much of a credit history, and the assumption is that people will order multiple home kits. And do what with them? No idea. You can’t process them without a lab, so I doubt they’re worth much on the street.

The woman was on the electoral roll and had a bank account and utility bills in her name, so she could prove her existence in the world, but not in the specified way.

Anna Miller, from Doctors of the World, questioned whether setting this limitation solved a problem that didn’t exist, and in the process locked out people with minimal credit history, “people whose financial situations tend to be organised by other people in a family”–young adults, the elderly, and women, not to mention people with low incomes.

*

The government has backed down in the face of Marcus Rashford, a twenty-something football player, over a million signatures on a petition, and many individuals and businesses: It has agreed to provide low-income kids in England–the ones who’d normally get free school lunches–with lunches over the Christmas holiday

Scotland, Wales, and Northern Ireland have already committed to do this. Only England was digging its heels in, and over the last holiday, called half term (don’t ask),it left them lunchless. At a time when so many people’s incomes have disappeared and people are turning to food shelves in large numbers, small businesses filled the gap in endless, often touching, ways, some out of their own pockets and some with the help of customer contributions. 

They’ve shamed the government into doing the right thing.